Hepatocellular Carcinoma in Ceará: Epidemiology and Treatment in a Reference Liver Transplant Center in Northeast Brazil
Transplantation Proceedings · 2024
DOI: 10.1016/j.transproceed.2024.01.024 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Transplantation Proceedings, 2024. Verfasst von P E G Costa und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Federal University of Ceará, Ceará, Brazil. Electronic address: pegcosta1@gmail.com. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Liver Transplantation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 16 Literaturangaben.
Abstract (Originalsprache)
Hepatocellular carcinoma remains a significant worldwide malignancy and an important cause of cancer-related death. The incidence is increasing globally. In Latin America, there is no consistent data on the epidemiology of hepatocellular carcinoma. However, Brazil is considered a country with an intermediate incidence of this liver neoplasm. In the state of Ceará, situated in the northeast region of Brazil, there are no consistent clinical and epidemiologic data on the actual incidence and the treatment of hepatocellular carcinoma. The purpose of this article is to describe epidemiologic characteristics and treatment forms of patients with hepatocellular carcinoma who were treated in a Liver Transplant Center. A retrospective observational study was conducted using the database from the register of 299 patients with hepatocellular carcinoma between June 2004 and February 2022. Only patients born in Ceará were included. Therefore, most patients were eligible, based on the Milan Criteria, to undergo liver transplantation with a Model End Stage Liver Disease score of 12.48 ± 4.66 points, and the waiting list time was approximately 7 months with 8.7% hepatocellular carcinoma recurrence after liver transplant. A total of 38.5 % of cases were outside the Milan criteria at the time of cancer diagnosis, and transarterial chemoembolization was the main treatment choice. In conclusion, the diagnosis of hepatocellular carcinoma in Ceará mainly occurs in male patients with hepatitis C or alcoholism, with a mean age of 61.55 years and a previous diagnosis of liver disease. Liver transplantation was the best curative therapeutic form in patients with cirrhosis and hepatocellular carcinoma in Ceará, where a significant number of patients were diagnosed with intermediate and advanced-stage hepatocellular carcinoma, so public health policies are important for the screening and monitoring of liver disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Surgery, Federal University of Ceará, Ceará, Brazil. Electronic address: pegcosta1@gmail.com.
- Department of Surgery, Federal University of Ceará, Ceará, Brazil.
- Christus University Center, Ceará, Brazil.
Zitieren
APA
Costa, P. E. G., Garcia, J. H. P., Coelho, G. R., Barros, M. A. P., Hyppolito, E. B., Pereira, K. B., Rocha, T. D. D. S., & Costa, G. C. G. (2024). Hepatocellular Carcinoma in Ceará: Epidemiology and Treatment in a Reference Liver Transplant Center in Northeast Brazil. Transplantation Proceedings. https://doi.org/10.1016/j.transproceed.2024.01.024
Vancouver
Costa PEG, Garcia JHP, Coelho GR, Barros MAP, Hyppolito EB, Pereira KB, et al. Hepatocellular Carcinoma in Ceará: Epidemiology and Treatment in a Reference Liver Transplant Center in Northeast Brazil. Transplantation Proceedings. 2024. doi:10.1016/j.transproceed.2024.01.024
BibTeX
@article{Costa2024,
author = {Costa, P E G and Garcia, J H P and Coelho, G R and Barros, M A P and Hyppolito, E B and Pereira, K B and Rocha, T D Dos S and Costa, G C G},
title = {Hepatocellular Carcinoma in Ceará: Epidemiology and Treatment in a Reference Liver Transplant Center in Northeast Brazil},
journal = {Transplantation Proceedings},
year = {2024},
doi = {10.1016/j.transproceed.2024.01.024}
}
EUVIMED